ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

IBT International Biotechnology Trust Plc

637.00
-5.00 (-0.78%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust Plc LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.00 -0.78% 637.00 632.00 640.00 646.00 640.00 640.00 52,085 16:35:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty 12.06M 6.81M 0.1733 36.93 251.64M

Intl. Biotechnology Trust PLC Net Asset Value(s) (4930U)

29/07/2020 11:35am

UK Regulatory


International Biotechnol... (LSE:IBT)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more International Biotechnol... Charts.

TIDMIBT

RNS Number : 4930U

Intl. Biotechnology Trust PLC

29 July 2020

International Biotechnology Trust plc

Net Asset Values

The Board of International Biotechnology Trust plc announces that the unaudited net asset value per share

 
 Date              NAV           Pence 
 Tuesday 28 Jul    Ex Income     754.10 
                  ------------  ------- 
 Tuesday 28 Jul    Cum Income    748.68 
                  ------------  ------- 
 

The above disclosure on NAV categorisation is as per the AIC guidance note "NAVs published via Regulatory Information Service (RIS) Platforms" issued 3 July 2007

29-Jul-2020

Enquiries:

International Biotechnology Trust plc

James Costine

SV Health Managers LLP

020 7421 7070

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NAVPPUCWMUPUGUB

(END) Dow Jones Newswires

July 29, 2020 06:35 ET (10:35 GMT)

1 Year International Biotechnol... Chart

1 Year International Biotechnol... Chart

1 Month International Biotechnol... Chart

1 Month International Biotechnol... Chart

Your Recent History

Delayed Upgrade Clock